Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
112.40
+3.10 (2.84%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $9.35 billion as of October 9, 2026. It is the 2,287th most valuable company in the world and the 803rd biggest in the United States. Its market cap has increased by 132.23% in one year.
Market Cap
9.35B
Enterprise Value
7.92B
1-Year Change
132.23%
Global Rank
Country Rank
#803 United States
Category
ChartMarket Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $9.35B, an increase of 1,019.99%. That is a compound annual growth rate of 48.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 9.35B | 50.15% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 10.47B |
| ImmunityBio | 10.27B |
| Vaxcyte | 9.93B |
| Krystal Biotech | 9.67B |
| Axsome Therapeutics | 9.13B |
| Protagonist Therapeutics | 8.97B |
| Arrowhead Pharmaceuticals | 8.69B |
| Cytokinetics | 8.53B |